Viewing StudyNCT04394624

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 2:42 PM
Last Modification Date: 2024-10-26 @ 1:35 PM
Study NCT ID: NCT04394624
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-05-01
First Post: 2020-05-14
Brief Title: Tusamitamab Ravtansine SAR408701 in Combination With Ramucirumab or Ramucirumab and Pembrolizumab in Pretreated Patients With NSQ NSCLC CARMEN-LC04
Sponsor: Sanofi
Organization: Sanofi
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Non-small Cell Lung Cancer Metastatic
Keywords: